Skip to content

Clinical trials

Completed Gaucher Disease trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gaucher Disease Status: Completed Country / region: United States Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20051
20063
20074
20085
20093
20102
20114
20131
20141
20154
20162
20181
20192
20212
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed47

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Genzyme, a Sanofi Company8
National Institute of Neurological Disorders and Stroke (NINDS)6
Amicus Therapeutics4
Sanofi4
Shire4
Pfizer3
University of Minnesota3
National Human Genome Research Institute (NHGRI)2
Takeda2
Children's Hospital Medical Center, Cincinnati1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gaucher Disease47
Metabolism, Inborn Errors5
Parkinson Disease4
Lysosomal Storage Diseases3
Sphingolipidoses3
Adrenoleukodystrophy2
Fucosidosis2
Gangliosidosis, GM12
Genetic Diseases, Inborn2
Leukodystrophy, Globoid Cell2

Trials

Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.